Savara (SVRA) Amortizatization of Intangibles (2012 - 2026)

Savara's (SVRA) quarterly Amortizatization of Intangibles came in at $565000.0 in Q1 2026, down 50.83% year-on-year from $1.1 million in Q1 2025, and up 15.31% on a QoQ basis from $490000.0 in Q4 2025.

Savara (SVRA) Amortizatization of Intangibles (2012 - 2026) Analysis & Trends

Savara (SVRA) has 8 years of Amortizatization of Intangibles data on file, last reported at $565000.0 in Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 50.83% year-over-year to $565000.0 in Q1 2026; TTM through Mar 2026 was $2.3 million, a 56.29% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, down 47.34% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $565000.0, up from $490000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for SVRA reached as high as $1.6 million in Q4 2023 and fell as low as -$267000.0 in Q1 2022.
  • Historically, Amortizatization of Intangibles has averaged $810705.9 across 5 years, with a median of $913000.0 in 2023.
  • Across the five-year window, Amortizatization of Intangibles jumped 2572.13% in 2023 and plunged 71.16% in 2025, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $357000.0 in 2022, then surged by 359.1% to $1.6 million in 2023, then declined by 10.31% to $1.5 million in 2024, then slumped by 66.67% to $490000.0 in 2025, then gained by 15.31% to $565000.0 in 2026.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $565000.0 in Q1 2026, $490000.0 in Q4 2025, and $426000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Savara 1.39 Bn 1.39 Bn - 565,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 565,000.00
Mar 31, 2026 565,000.00
Dec 31, 2025 490,000.00
Dec 31, 2025 490,000.00
Sep 30, 2025 426,000.00
Sep 30, 2025 426,000.00
Jun 30, 2025 801,000.00
Jun 30, 2025 801,000.00
Mar 31, 2025 1.15 Mn
Mar 31, 2025 1.15 Mn
Dec 31, 2024 1.47 Mn
Dec 31, 2024 1.47 Mn
Sep 30, 2024 1.48 Mn
Sep 30, 2024 1.48 Mn
Jun 30, 2024 1.13 Mn
Jun 30, 2024 1.13 Mn
Mar 31, 2024 1.37 Mn
Mar 31, 2024 1.37 Mn
Dec 31, 2023 1.64 Mn
Dec 31, 2023 1.64 Mn